Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
2001
|
| _version_ | 1826287451616837632 |
|---|---|
| author | Lundin, J Kimby, E Bjorkholm, M Celsing, F Hale, G Hjalmar, V Merup, M Petrescu, A Tullgren, O Waldmann, H Mellstedt, H Osterborg, A |
| author_facet | Lundin, J Kimby, E Bjorkholm, M Celsing, F Hale, G Hjalmar, V Merup, M Petrescu, A Tullgren, O Waldmann, H Mellstedt, H Osterborg, A |
| author_sort | Lundin, J |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T01:58:52Z |
| format | Journal article |
| id | oxford-uuid:9cabf927-2488-4a5a-b18a-b4c10106a696 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T01:58:52Z |
| publishDate | 2001 |
| record_format | dspace |
| spelling | oxford-uuid:9cabf927-2488-4a5a-b18a-b4c10106a6962022-03-27T00:37:35ZPhase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9cabf927-2488-4a5a-b18a-b4c10106a696Symplectic Elements at Oxford2001Lundin, JKimby, EBjorkholm, MCelsing, FHale, GHjalmar, VMerup, MPetrescu, ATullgren, OWaldmann, HMellstedt, HOsterborg, A |
| spellingShingle | Lundin, J Kimby, E Bjorkholm, M Celsing, F Hale, G Hjalmar, V Merup, M Petrescu, A Tullgren, O Waldmann, H Mellstedt, H Osterborg, A Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL). |
| title | Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL). |
| title_full | Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL). |
| title_fullStr | Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL). |
| title_full_unstemmed | Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL). |
| title_short | Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL). |
| title_sort | phase ii study of subcutaneous alemtuzumab campath 1h therapy of patients with previously untreated chronic lymphocytic leukemia cll |
| work_keys_str_mv | AT lundinj phaseiistudyofsubcutaneousalemtuzumabcampath1htherapyofpatientswithpreviouslyuntreatedchroniclymphocyticleukemiacll AT kimbye phaseiistudyofsubcutaneousalemtuzumabcampath1htherapyofpatientswithpreviouslyuntreatedchroniclymphocyticleukemiacll AT bjorkholmm phaseiistudyofsubcutaneousalemtuzumabcampath1htherapyofpatientswithpreviouslyuntreatedchroniclymphocyticleukemiacll AT celsingf phaseiistudyofsubcutaneousalemtuzumabcampath1htherapyofpatientswithpreviouslyuntreatedchroniclymphocyticleukemiacll AT haleg phaseiistudyofsubcutaneousalemtuzumabcampath1htherapyofpatientswithpreviouslyuntreatedchroniclymphocyticleukemiacll AT hjalmarv phaseiistudyofsubcutaneousalemtuzumabcampath1htherapyofpatientswithpreviouslyuntreatedchroniclymphocyticleukemiacll AT merupm phaseiistudyofsubcutaneousalemtuzumabcampath1htherapyofpatientswithpreviouslyuntreatedchroniclymphocyticleukemiacll AT petrescua phaseiistudyofsubcutaneousalemtuzumabcampath1htherapyofpatientswithpreviouslyuntreatedchroniclymphocyticleukemiacll AT tullgreno phaseiistudyofsubcutaneousalemtuzumabcampath1htherapyofpatientswithpreviouslyuntreatedchroniclymphocyticleukemiacll AT waldmannh phaseiistudyofsubcutaneousalemtuzumabcampath1htherapyofpatientswithpreviouslyuntreatedchroniclymphocyticleukemiacll AT mellstedth phaseiistudyofsubcutaneousalemtuzumabcampath1htherapyofpatientswithpreviouslyuntreatedchroniclymphocyticleukemiacll AT osterborga phaseiistudyofsubcutaneousalemtuzumabcampath1htherapyofpatientswithpreviouslyuntreatedchroniclymphocyticleukemiacll |